Kunli Zhu

Jinan, Shandong

Disclosures:

• Employment: none
• Compensation: none
• Ownership: none
• Leadership: none

Presentation(s):

• 3126 - Efficacy and Safety of PD-1 Inhibitors and Targeted Drugs Combined with Radiotherapy in First-Line Treatment of Oligometastatic Hepatocellular Carcinoma

  Tuesday, October 1, 2024
  12:45 PM – 2:00 PM ET